Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vildagliptin in Type 2 Diabetes with Renal Insufficiency (Extension)
NCT00765830Phase 3Completed
- Sponsor
- Novartis
- Start
- Sep 2008
- Primary completion
- Apr 2011
- Countries
- 12
01
Overview
A Phase 3 trial of vildagliptin in type 2 diabetes mellitus (T2DM), sponsored by Novartis. Started Sep 2008; status: completed.
02
Drugs
vildagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00765830.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00765830.